Product Information
LANSOPRAZOLE DR 15 MG CAPSULE is a generic product labeled by Ascend Laboratories, LLC, priced at $0.1474 per EA under NDC 67877027430. Its NADAC has been published 344 times since Mar 4, 2020.
FDA first approved this application on Jan 18, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
15 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877027430
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LANSOPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA207394FDA Approved
1/18/2019
TE Code
AB
On Market Since
1/20/2019
Pharmacological Classes
Price Statistics
The NADAC for LANSOPRAZOLE DR 15 MG CAPSULE has been published 344 times since Mar 4, 2020, and over the history we have for it it has declined 60.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1474 per EA |
|---|---|
| All-time high | $0.3909 (Jun 16, 2021) |
| All-time low | $0.1227 (Nov 20, 2024) |
| 52-week high | $0.1754 |
| 52-week low | $0.1470 |
| Median price | $0.2239 |
| Average price | $0.2354 |
| Largest weekly change | +44.5% (Jun 19, 2024) |
| Weeks tracked | 344 |
| Tracking since | Mar 4, 2020 |
Generic Alternatives
The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ascend Laboratories, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lansoprazole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Proton Pump Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LANSOPRAZOLE DR 15 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for LANSOPRAZOLE DR 15 MG CAPSULE, manufactured by Ascend Laboratories, LLC, is $0.1474 per EA (NDC 67877027430), effective Sep 30, 2026.
How has the price of LANSOPRAZOLE DR 15 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for LANSOPRAZOLE DR 15 MG CAPSULE has declined 60.5%. It has been tracked across 344 weekly CMS publications since Mar 4, 2020.
What are the highest and lowest recorded NADAC prices for LANSOPRAZOLE DR 15 MG CAPSULE?
Since Mar 4, 2020, the NADAC for LANSOPRAZOLE DR 15 MG CAPSULE has ranged from a low of $0.1227 (Nov 20, 2024) to a high of $0.3909 (Jun 16, 2021), with a median of $0.2239 per EA.
Are there cheaper alternatives to LANSOPRAZOLE DR 15 MG CAPSULE?
12 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LANSOPRAZOLE DR 15 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures LANSOPRAZOLE DR 15 MG CAPSULE?
LANSOPRAZOLE DR 15 MG CAPSULE (NDC 67877027430) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.